{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:54:23Z","timestamp":1792180463054,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Beijing Municipal Administration of Hospitals\u2019 Youth Programme","award":["QML20210203"],"award-info":[{"award-number":["QML20210203"]}]},{"name":"R&D Program of Beijing Municipal Education Commission","award":["KM202210025014"],"award-info":[{"award-number":["KM202210025014"]}]},{"name":"Beijing Natural Science- Foundation Program and Scientific Research Key Program of Beijing Municipal Commission of Education","award":["KZ201910025034"],"award-info":[{"award-number":["KZ201910025034"]}]},{"DOI":"10.13039\/501100012167","name":"National Science and Technology Infrastructure Program","doi-asserted-by":"publisher","award":["2020YFB1312805"],"award-info":[{"award-number":["2020YFB1312805"]}],"id":[{"id":"10.13039\/501100012167","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bei-jing Municipal Administration of Hospitals\u2019 Ascent Plan","award":["DFL20180202"],"award-info":[{"award-number":["DFL20180202"]}]},{"DOI":"10.13039\/501100010270","name":"The Capital Health Research and Development of Special","doi-asserted-by":"crossref","award":["2022-1-2051"],"award-info":[{"award-number":["2022-1-2051"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10637-024-01456-w","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T08:58:34Z","timestamp":1732784314000},"page":"694-702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Neoadjuvant immunochemotherapy in locally advanced laryngeal cancer and hypopharyngeal cancer: higher objective response rate and organ-preservation rate"],"prefix":"10.1007","volume":"42","author":[{"given":"Shaoshi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jugao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"issue":"6","key":"1456_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1456_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.otohns.2003.08.028","volume":"131","author":"SR Schwartz","year":"2004","unstructured":"Schwartz SR, Yueh B, Maynard C, Daley J, Henderson W, Khuri SF (2004) Predictors of wound complications after laryngectomy A study of over 2000 patients. Otolaryngol-head neck surg. 131(1):61\u201368","journal-title":"Otolaryngol-head neck surg."},{"issue":"10","key":"1456_CR3","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/cncr.30483","volume":"123","author":"G RyanP","year":"2017","unstructured":"RyanP G, Hutcheson KA, Lewin JS, Desai NG, Zafereo ME, Hessel AC et al (2017) Complications, hospital length of stay, and readmission after total laryngectomy. Cancer 123(10):1760\u20131767","journal-title":"Cancer"},{"issue":"24","key":"1456_CR4","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","volume":"324","author":"GT Wolf","year":"1991","unstructured":"Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE et al (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324(24):1685\u20131690","journal-title":"N Engl J Med"},{"issue":"10","key":"1456_CR5","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1093\/annonc\/mds065","volume":"23","author":"JL Lefebvre","year":"2012","unstructured":"Lefebvre JL, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L et al (2012) Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891. Ann Oncol 23(10):2708\u20132714","journal-title":"Ann Oncol"},{"issue":"10","key":"1456_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100426","volume":"2","author":"HM Knochelmann","year":"2021","unstructured":"Knochelmann HM, Horton JD, Liu S, Armeson K, Kaczmar JM, Wyatt MM et al (2021) Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Reports Medicine 2(10):100426","journal-title":"Cell Reports Medicine"},{"issue":"10212","key":"1456_CR7","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","volume":"394","author":"B Burtness","year":"2019","unstructured":"Burtness B, Harrington KJ, Greil R, Souli\u00e8res D, Tahara M, De Castro G et al (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. The Lancet 394(10212):1915\u20131928","journal-title":"The Lancet"},{"key":"1456_CR8","doi-asserted-by":"crossref","unstructured":"Mandal R, \u015eenbabao\u011flu Y, Desrichard A, Havel JJ, Dalin MG, Riaz N, et al (2016) The head and neck cancer immune landscape and its immunotherapeutic implications. JCI Insight [Internet]. 2016 Oct 20 [cited 2023 Dec 21];1(17). Available from: https:\/\/insight.jci.org\/articles\/view\/89829","DOI":"10.1172\/jci.insight.89829"},{"key":"1456_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106479","volume":"145","author":"S Chen","year":"2023","unstructured":"Chen S, Yang Y, Wang R, Fang J (2023) Neoadjuvant PD-1\/PD-L1 inhibitors combined with chemotherapy had a higher ORR than mono-immunotherapy in untreated HNSCC: Meta-analysis. Oral Oncol 145:106479","journal-title":"Oral Oncol"},{"key":"1456_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, De Vries E, Ford R, Gwyther S, Mandrekar S et al (2016) RECIST 1.1\u2013Update and clarification: From the RECIST committee. Eur J Cancer 62:132\u2013137","journal-title":"Eur J Cancer"},{"issue":"5","key":"1456_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Rad Oncol Biol Phys. 31(5):1341\u20131346","journal-title":"Int J Rad Oncol Biol Phys."},{"issue":"12","key":"1456_CR12","first-page":"1143","volume":"55","author":"YF Yang","year":"2020","unstructured":"Yang YF, Wang R, Fang JG, Zhong Q, Huang ZG, Chen XH et al (2020) A single-arm prospective study on induction chemotherapy and subsequent comprehensive therapy for advanced hypopharyngeal squamous cell carcinoma: report of 260 cases in a single center. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 55(12):1143\u20131153","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"1456_CR13","doi-asserted-by":"crossref","unstructured":"Ma J, Liu Y, Yang X, Zhang C ping, Zhang Z yuan, Zhong L ping (2013) Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis. World J Surg Onc. 11(1):67","DOI":"10.1186\/1477-7819-11-67"},{"issue":"17","key":"1456_CR14","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa071028","volume":"357","author":"JB Vermorken","year":"2007","unstructured":"Vermorken JB, Remenar E, Van Herpen C, Gorlia T, Mesia R, Degardin M et al (2007) Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer. N Engl J Med 357(17):1695\u20131704","journal-title":"N Engl J Med"},{"key":"1456_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106560","volume":"146","author":"YP Merchant","year":"2023","unstructured":"Merchant YP, Mehta V, Aaqib Shamim M, Shah A, Shetty R (2023) Cost-benefit analysis of immune checkpoint inhibitors: Is the price worth their value? Oral Oncol 146:106560","journal-title":"Oral Oncol"},{"issue":"14","key":"1456_CR16","doi-asserted-by":"publisher","first-page":"1282629","DOI":"10.3389\/fimmu.2023.1282629","volume":"14","author":"WJ Wu","year":"2023","unstructured":"Wu WJ, Liu Q, An PG, Wang L, Zhang JY, Chen Y et al (2023) Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real\u2212world retrospective study. Front Immunol 14(14):1282629","journal-title":"Front Immunol"},{"issue":"1","key":"1456_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41568-022-00529-3","volume":"23","author":"A Wahida","year":"2023","unstructured":"Wahida A, Buschhorn L, Fr\u00f6hling S, Jost PJ, Schneeweiss A, Lichter P et al (2023) The coming decade in precision oncology: six riddles. Nat Rev Cancer 23(1):43\u201354","journal-title":"Nat Rev Cancer"},{"key":"1456_CR18","doi-asserted-by":"crossref","unstructured":"Mariniello A, Nasti TH, Chang DY, Hashimoto M, Malik S, McManus DT, et al (2023) Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade. Clin Cancer Res OF1\u201313","DOI":"10.1158\/1078-0432.25728656.v1"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-024-01456-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-024-01456-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-024-01456-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T09:12:22Z","timestamp":1733562742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-024-01456-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1456"],"URL":"https:\/\/doi.org\/10.1007\/s10637-024-01456-w","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has passed the ethical review from Ethics Committee of Beijing Tongren Hospital, Capital Medical University (No TREC2023-KY022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical review"}},{"value":"This study involving human participants or patient material (tissue\/blood samples) has obtained informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rarticipants or patient material"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}